Enzymotec Seeks $100 Million Nasdaq Exit

– Enzymotec Ltd. Files Registration Statement for Proposed Secondary Offering – –  Enzymotec Ltd. (Nasdaq:ENZY) today announced that it has filed a registration statement on Form F-1 with More...

Enzymotec raises $63.5 million in Nasdaq IPO

– The lipid-based products developer held the IPO at $14 per share, below its target of $16-18, but the share price rose 30% on Friday. – – Enzymotec Ltd. (Nasdaq: ENZY) has raised a net More...